Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer
Thoracic re-RT with PBT is an option for recurrent NSCLC with acceptable outcomes and toxicity for select patients. When feasible, higher prescription doses (BED10 > 70 Gy) should be delivered for definitive intent, and concurrent chemotherapy may benefit individual cases.
Authors
- Abigael Odwuor
- Percy Lee (ORCID: https://orcid.org/0000-0001-6004-840X)
- Joe Y. Chang (ORCID: https://orcid.org/0000-0002-8435-2083)
- Julianna Bronk (ORCID: https://orcid.org/0000-0003-3459-1833)
- Stephen G. Chun (ORCID: https://orcid.org/0000-0002-4324-8044)
- Matthew S. Ning (ORCID: https://orcid.org/0000-0002-2932-5584)
- Aileen B. Chen (ORCID: https://orcid.org/0000-0002-5385-3360)
- Steven Hsesheng Lin (ORCID: https://orcid.org/0000-0003-4411-0634)
- David C. Qian (ORCID: https://orcid.org/0000-0002-8459-009X)
- James W. Welsh (ORCID: https://orcid.org/0000-0002-2255-8502)
- Zhongxing Liao (ORCID: https://orcid.org/0000-0002-2224-9478)
- Quynh‐Nhu Nguyen (ORCID: https://orcid.org/0000-0001-5274-6291)
- Michael S. O’Reilly
- Saumil Gandhi (ORCID: https://orcid.org/0000-0002-3349-3521)
Institutions
- City Of Hope National Medical Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- City of Hope (US)
Publication Details
- Journal
- Cancers
- Published
- 2024-10-24
- DOI
- https://doi.org/10.3390/cancers16213587
- Citations
- 3
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.26